Ca. Maggi et al., EVIDENCE FOR THE INVOLVEMENT OF BRADYKININ IN CHEMICALLY-EVOKED CYSTITIS IN ANESTHETIZED RATS, Naunyn-Schmiedeberg's archives of pharmacology, 347(4), 1993, pp. 432-437
The effect of Hoe 140, a potent bradykinin B2 receptor antagonist, on
the micturition reflex and detrusor hyperreflexia induced by chemical
cystitis has been investigated in anaesthetized rats. Hoe 140, (I - 10
0 nmol/kg i. v.) produced a dose-dependent blockade of the contraction
of the rat urinary bladder induced by i. v. administration of bradyki
nin (100 nmol/kg) without affecting the response produced by the selec
tive tachykinin NK-1 receptor agonist, [Sar9] substance P (SP) sulfone
(1 nmol/kg i. v.). At doses which produce selective and long-lasting
blockade of bradykinin receptors in the urinary bladder, Hoe 140 did n
ot modify urodynamic parameters in normal rats. Intravesical instillat
ion of xylene in female rats decreased bladder capacity and increased
micturition frequency. These effects also occurred in rats pretreated
with capsaicin as adults. Hoe 140 did not modify xylene-induced cystit
is. Intraperitoneal administration of cyclophosphamide (150 mg/kg, 48
h before) decreased bladder capacity and increased micturition frequen
cy. These effects of cyclophosphamide were abolished in rats pretreate
d with capsaicin as adults. Hoe 140 increased bladder capacity and dec
reased micturition frequency in rats pretreated with cyclophosphamide.
Addition of bradykinin (10 mumol/l) to the medium in the superfused r
at urinary bladder preparation evoked a prompt increase in the outflow
of calcitonin gene-related peptide like immunoreactivity (CGRP-LI). H
oe 140 (3 mumol/1) inhibited (by about 50%) the CGRP-LI outflow stimul
ated by bradykinin. These findings demonstrate the participation of br
adykinin, through B 2 receptors, in the genesis of detrusor hyperrefle
xia during cyclophosphamide-induced cystitis. Capsaicin-sensitive prim
ary afferent neurons are a likely target for Hoe 140 action in this mo
del of experimental cystitis, as exemplified by its ability to prevent
CGRP-LI outflow by bradykinin.